Cardan Capital Partners’s Bio-Techne TECH Stock Holding History

Cardan Capital Partners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$436K	Hold	3,600	–	–	0.05%	165
2021 Q2	$405K	Hold	3,600	–	–	0.05%	175
2021 Q1	$344K	Hold	3,600	–	–	0.04%	176
2020 Q4	$286K	Hold	3,600	–	–	0.04%	187
2020 Q3	$223K	Sell	3,600 -96	-3%	-$6.25K	0.03%	212
2020 Q2	$244K	Buy	+3,696	New	+$221K	0.03%	202

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Cardan Capital Partners's TECH Position: Q3 2021 in Review

Cardan Capital Partners held its Bio-Techne (TECH) position steady in Q3 2021 at 3,600 shares worth $436K. The position accounts for 0.05% of the portfolio, ranked #165.

Cardan Capital Partners first reported a position in TECH in Q2 2020 and has held it in 6 quarters since. 565 funds tracked by Wall St. Rank hold TECH as of Q3 2021.

Cardan Capital Partners held 3,600 shares of Bio-Techne worth $436K as of Q3 2021.
Cardan Capital Partners left its Bio-Techne share count unchanged in Q3 2021.
Bio-Techne made up 0.05% of Cardan Capital Partners's portfolio in Q3 2021, its #165 holding.
Cardan Capital Partners first reported a position in Bio-Techne in Q2 2020 and has held it in 6 quarters since.
565 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2021.

Based on Cardan Capital Partners's 13F filing for Q3 2021, filed 25 Oct 2021.